PharmaEngine, Inc. 4162.TWO Stock
PharmaEngine, Inc. Price Chart
PharmaEngine, Inc. 4162.TWO Financial and Trading Overview
| PharmaEngine, Inc. stock price | 94 TWD |
| Previous Close | 93.2 TWD |
| Open | 94 TWD |
| Bid | 94 TWD x 0 |
| Ask | 94.1 TWD x 0 |
| Day's Range | 93.5 - 94.8 TWD |
| 52 Week Range | 75.3 - 150.5 TWD |
| Volume | 669.78K TWD |
| Avg. Volume | 1.55M TWD |
| Market Cap | 13.52B TWD |
| Beta (5Y Monthly) | 0.951369 |
| PE Ratio (TTM) | 43.76744 |
| EPS (TTM) | 1.91 TWD |
| Forward Dividend & Yield | 2.7 (2.90%) |
| Ex-Dividend Date | August 15, 2022 |
| 1y Target Est | 107 TWD |
4162.TWO Valuation Measures
| Enterprise Value | 9.64B TWD |
| Trailing P/E | 43.76744 |
| Forward P/E | 11.531863 |
| PEG Ratio (5 yr expected) | 1.62 |
| Price/Sales (ttm) | 20.846775 |
| Price/Book (mrq) | 3.4188344 |
| Enterprise Value/Revenue | 14.861 |
| Enterprise Value/EBITDA | 38.84 |
Trading Information
PharmaEngine, Inc. Stock Price History
| Beta (5Y Monthly) | 0.951369 |
| 52-Week Change | 16.49% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 150.5 TWD |
| 52 Week Low | 75.3 TWD |
| 50-Day Moving Average | 98.29 TWD |
| 200-Day Moving Average | 113.37 TWD |
4162.TWO Share Statistics
| Avg. Volume (3 month) | 1.55M TWD |
| Avg. Daily Volume (10-Days) | 793K TWD |
| Shares Outstanding | 143.69M |
| Float | 93.31M |
| Short Ratio | N/A |
| % Held by Insiders | 22.57% |
| % Held by Institutions | 23.29% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 2 |
| Trailing Annual Dividend Yield | 2.14% |
| 5 Year Average Dividend Yield | 194.00% |
| Payout Ratio | 1.2796 |
| Last Split Factor | 1199.953:1000 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 46.73% |
| Operating Margin (ttm) | 38.11% |
| Gross Margin | 92.03% |
| EBITDA Margin | 38.26% |
Management Effectiveness
| Return on Assets (ttm) | 3.78% |
| Return on Equity (ttm) | 7.58% |
Income Statement
| Revenue (ttm) | 648.59M TWD |
| Revenue Per Share (ttm) | 4.52 TWD |
| Quarterly Revenue Growth (yoy) | -3.30% |
| Gross Profit (ttm) | 604.68M TWD |
| EBITDA | 248.17M TWD |
| Net Income Avi to Common (ttm) | 303.13M TWD |
| Diluted EPS (ttm) | 2.15 |
| Quarterly Earnings Growth (yoy) | -16.10% |
Balance Sheet
| Total Cash (mrq) | 3.76B TWD |
| Total Cash Per Share (mrq) | 26.16 TWD |
| Total Debt (mrq) | 20.47M TWD |
| Total Debt/Equity (mrq) | 0.52 TWD |
| Current Ratio (mrq) | 48.857 |
| Book Value Per Share (mrq) | 27.524 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 228.54M TWD |
| Levered Free Cash Flow (ttm) | 134.76M TWD |
Profile of PharmaEngine, Inc.
| Country | Taiwan |
| State | N/A |
| City | Taipei |
| Address | 10 Minsheng East Road |
| ZIP | 104 |
| Phone | 886 2 2515 8228 |
| Website | https://www.pharmaengine.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
PharmaEngine, Inc., a biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan and Europe. It is developing ONIVYDE, a proprietary liposome encapsulation of irinotecan, a topoisomerase 1 inhibitor for the treatment of metastatic pancreatic cancer; PEP06, which is in Phase I clinical trial for the treatment of cancer; and PEP07, a Chk1 inhibitor, which is in preclinical development stage to accumulate DNA damage in cells, lead to replication catastrophe, and induce cell apoptosis. PharmaEngine, Inc. was incorporated in 2002 and is headquartered in Taipei, Taiwan.
Q&A For PharmaEngine, Inc. Stock
What is a current 4162.TWO stock price?
PharmaEngine, Inc. 4162.TWO stock price today per share is 94 TWD.
How to purchase PharmaEngine, Inc. stock?
You can buy 4162.TWO shares on the Taipei Exchange exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for PharmaEngine, Inc.?
The stock symbol or ticker of PharmaEngine, Inc. is 4162.TWO.
Which industry does the PharmaEngine, Inc. company belong to?
The PharmaEngine, Inc. industry is Biotechnology.
How many shares does PharmaEngine, Inc. have in circulation?
The max supply of PharmaEngine, Inc. shares is 143.68M.
What is PharmaEngine, Inc. Price to Earnings Ratio (PE Ratio)?
PharmaEngine, Inc. PE Ratio is 49.21466000 now.
What was PharmaEngine, Inc. earnings per share over the trailing 12 months (TTM)?
PharmaEngine, Inc. EPS is 1.91 TWD over the trailing 12 months.
Which sector does the PharmaEngine, Inc. company belong to?
The PharmaEngine, Inc. sector is Healthcare.